iCAD: Prostate & Breast MRI Imaging Technologies
| Company News - iCAD, Inc. |
iCAD Takes Leadership Position in Meeting the Need for Accredited Educational Initiatives on Prostate and Breast MRI Imaging Technologies.
iCAD, Inc. , an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announces upcoming educational initiatives for physicians who diagnose and treat patients with breast and prostate cancers. iCAD has provided a grant to ICPME for a comprehensive educational webinar series. These accredited educational webinar sessions will be offered throughout 2010 with presentations by expert clinical faculty from leading institutions across the country and are designed to:
- Educate clinicians on the indications for use of MRI with prostate and breast cancer -- Detection
- Diagnosis
- Staging
- Treatment planning and monitoring
- Provide a detailed review of MRI images including case interpretation
- Review the technical aspects of breast and prostate MRI exams
- Guide clinicians in how to use MRI and advanced image analysis technology as part of the overall interpretation and standardization of reporting.
Four key areas have been consistently identified relative to prostate cancer MRI education and training; these include MRI indications and technique, MRI for cancer detection and localization, MRI for treatment planning and therapy monitoring, and future and evolving applications of prostate MRI. The prostate webinar series, "Common Practices in Prostate MRI," will include didactic lecture and case review.
Additionally, some of the nation's leading radiologists will deliver, "Decisions in Medical Imaging," a breast MRI webinar series. Based on recent evidence on the efficacy of breast MRI screening in high risk patients, the American Cancer Society issued guidelines for the early detection of breast cancer which include MRI. Additionally, MRI is emerging as an important tool in the treatment of breast cancer patients to evaluate the extent of disease, assess tumor response to neoadjuvant chemotherapy, and for surgeons in preoperative planning. This program brings to learners the opportunity to view a variety of breast MRI cases as expert faculty share their experience and approach to breast MRI in their own breast MRI practice.
"As a leader in advanced image analysis MRI solutions, iCAD is focused on continuing its educational initiative to improve the general understanding of how imaging protocols support earlier detection, better patient care and improved outcomes," said Ken Ferry, President and CEO of iCAD. "ICPME is a recognized leader in educational activities designed to improve practice performance and patient care. We look forward to working with them to provide valuable educational resources to clinicians who want to adopt MRI into their practices as this advanced imaging technique, when used with a quantitative image analysis software solution, has been proven to show improvements in cancer detection, treatment planning and management."
Source: iCAD, Inc.




